Kay specializes in representing public and private life sciences companies in a wide range of securities, corporate and commercial matters that are critical to their businesses. She advises biotechnology, diagnostic and device companies on complex commercial transactions, including technology licenses and acquisitions, research and development collaborations, supply, distribution and manufacturing agreements and profit-sharing and co-promotion arrangements, based on her extensive experience in assisting clients to establish and maintain relationships with pharmaceutical, diagnostic, medical device, energy, chemical and agricultural companies in the United States, Europe and Asia. She also counsels clients on securities and corporate matters, including private financings, public offerings, mergers and acquisitions and corporate governance and disclosure issues. She works closely with her clients to understand each client's business and strategic objectives and to structure and negotiate transactions to meet those objectives.
Download full bio